Skip to main content
Equibles

PROFUND ADVISORS LLC

Position in SMMT — Summit Therapeutics Inc.

CIK 1129919 BETHESDA, MD
Back to SMMT Full portfolio

Position in SMMT

as of Jun 30, 2026 · filed Aug 11, 2026
Position Value
$1,464,998
-$676,078 QoQ
Shares Held
100,549
-11.0% QoQ
Ownership
0.013%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#75
of 242 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in SMMT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

PROFUND ADVISORS LLC holds $165,155,882 across 170 Biotechnology names. SMMT ranks #46 (0.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 23,398 $11,622,488
2 REGN
Regeneron Pharmaceuticals, Inc.
 10,444 $6,512,251
3 ALNY
Alnylam Pharmaceuticals, Inc.
 13,814 $4,158,428
4 MRNA
Moderna, Inc.
 33,142 $2,320,934
5 APGE
Apogee Therapeutics, Inc.
 17,163 $2,278,044
6 CYTK
Cytokinetics Inc
 25,572 $2,178,478
7 TWST
Twist Bioscience Corp
 21,095 $2,170,253
8 KRYS
Krystal Biotech, Inc.
 5,770 $2,144,535

All Filings in SMMT

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,464,998 100,549
2026-03-31 $2,141,076 112,926
2025-12-31 $1,814,779 103,761
2025-09-30 $1,444,815 69,933
2025-06-30 $843,539 39,640
2025-03-31 $910,179 47,184
2024-12-31 $1,057,798 59,277
2024-09-30 $488,786 22,319
2024-06-30 $243,375 31,202
2024-03-31 $418,202 101,015